Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study.
暂无分享,去创建一个
Linda Z. Sun | Linda Z Sun | H. Goldschmidt | K. Anderson | M. Dimopoulos | A. Palumbo | S. Lonial | D. Siegel | R. Hájek | T. Facon | S. Vuocolo | L. Rosiñol | V. Hungria | H. Blacklock | A. Spencer | T. Graef | J. Qi | Cathy D. Williams | J. Houp | C. Williams | J. Eid | K. Anderson